SB-01 (Ensol BioSciences)

N/A

Report date: 2024/07/11 14:02:38
NMEFirst In Class

Base Information

Drug NameSB-01 (Ensol BioSciences)
Drug Alias NameRemediscSB-01YH14618YH-14618P2K +[7] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionTransforming growth factor beta 1 inhibitors
TargetsTransforming growth factor beta 1
Therapy Area/IndicationsIntervertebral disc diseaseLow Back PainIntervertebral Disc Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesEnsol Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesSpine BioPharma Inc
Inactive CompaniesYuhan Corp
Active IndicationsIntervertebral disc diseaseLow Back PainIntervertebral Disc Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A